COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.
Saved in:
| Title: | COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection. |
|---|---|
| Authors: | Yeola A; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia., Houston S; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia., Aggarwal A; The Kirby Institute, The University of New South Wales, Sydney, Australia., Gamage R; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia., Maltby VE; Department of Neurology, John Hunter Hospital, Newcastle, Australia.; School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.; Hunter Medical Research Institute, University of Newcastle, Australia., Fabis-Pedrini MJ; The Perron Institute for Neurological and Translational Science, QEII Medical Centre, The University of Western Australia, Nedlands, WA, Australia.; Personalised Medicine Centre, Health Futures Institute, Murdoch University, Western Australia., Le-Kavanagh L; The Perron Institute for Neurological and Translational Science, QEII Medical Centre, The University of Western Australia, Nedlands, WA, Australia., Merheb V; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia., Nguyen K; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia., Lee FXZ; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia., Walters S; The Perron Institute for Neurological and Translational Science, QEII Medical Centre, The University of Western Australia, Nedlands, WA, Australia., Taha M; The University of Sydney, Brain and Mind Centre, Australia.; The University of Sydney, Faculty of Medicine and Health, Australia., O'Connell A; The University of Sydney, Brain and Mind Centre, Australia.; The University of Sydney, Faculty of Medicine and Health, Australia., Jokubaitis VG; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia.; Department of Neurology, MSNI Service, Alfred Health, Melbourne, Australia., Roldan A; Department of Neurology, MSNI Service, Alfred Health, Melbourne, Australia., Monif M; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia.; Department of Neurology, MSNI Service, Alfred Health, Melbourne, Australia., Butzkueven H; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia.; Department of Neurology, MSNI Service, Alfred Health, Melbourne, Australia., Sampangi S; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia., Rath L; Department of Neurology, MSNI Service, Alfred Health, Melbourne, Australia., Fazzolari K; Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia., Hardy TA; Department of Neurology, Concord Repatriation General Hospital, University of Sydney, Australia., Beadnall HN; The University of Sydney, Brain and Mind Centre, Australia., Barnett MH; The University of Sydney, Brain and Mind Centre, Australia.; The University of Sydney, Faculty of Medicine and Health, Australia., Kermode AG; The Perron Institute for Neurological and Translational Science, QEII Medical Centre, The University of Western Australia, Nedlands, WA, Australia.; Personalised Medicine Centre, Health Futures Institute, Murdoch University, Western Australia., Dwyer C; CORe, Department of Medicine, University of Melbourne, Australia; and., Kalincik T; Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.; CORe, Department of Medicine, University of Melbourne, Australia; and., Broadley SA; Department of Neurology, Gold Coast Hospital and Griffith University, Australia., Turville SG; The Kirby Institute, The University of New South Wales, Sydney, Australia., Reddel SW; The University of Sydney, Brain and Mind Centre, Australia.; The University of Sydney, Faculty of Medicine and Health, Australia.; Department of Neurology, Concord Repatriation General Hospital, University of Sydney, Australia., Ramanathan S; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia.; The University of Sydney, Brain and Mind Centre, Australia.; The University of Sydney, Faculty of Medicine and Health, Australia.; Department of Neurology, Concord Repatriation General Hospital, University of Sydney, Australia., Lechner-Scott J; Department of Neurology, John Hunter Hospital, Newcastle, Australia.; School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.; Hunter Medical Research Institute, University of Newcastle, Australia., Van Der Walt A; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia.; Department of Neurology, MSNI Service, Alfred Health, Melbourne, Australia., Brilot F; Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, Australia.; The University of Sydney, Brain and Mind Centre, Australia.; The University of Sydney, Faculty of Medicine and Health, Australia. |
| Source: | Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2025 Sep; Vol. 12 (5), pp. e200443. Date of Electronic Publication: 2025 Jul 22. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
